Seeking Alpha

David Greene's  Instablog

David Greene
Send Message
Trading and investing full time for personal account and consulting with a money manager firm with assets of over $55 Million. Worked on Wall Street for 18 years at two wirehouses and one boutique investment banking firm. Investment discipline includes taking advantage of Wall Street's tendency... More
My blog:
View David Greene's Instablogs on:
  • Competitive Technologies (CTTC) to be on Good Morning America Tomorrow
    This is a necessarily short post. CTTC will be the subject of segments on CTTC's technology which relieves Chronic Pain on TWO morning shows tomorrow.

    Good Morning America and The Early Show--between 7-9AM.

    A victim of a lightning strike in Utah posted will be interviewed on the two shows. What makes this of some potential importance to CTTC is that the patient experienced significant pain relief from the treatments and will be discussed tomorrow.

    After I have viewed the segments, I will follow up with more information.

    On a side note, the Mayo Clinic has posted on their website that they are conducting a clinical study on Calmare.

    Mar 14 3:46 PM | Link | 1 Comment
  • 3PAR Board Approval of DELL Offer is a Positive for HPQ
    Today's news that the 3PAR (NYSE:PAR) Board of Directors has approved the latest Dell offer to be acquired, assuming no further pursuit of 3PAR by Hewlett Packard (NYSE:HPQ), is a net positive for HPQ shareholders. The cloud overhanging HPQ since the previous CEO was given his walking papers for violating corporate polices has continued with HPQ's quest to overbid for 3PAR. Yes, HPQ has plenty of cash in its treasury, but the general consensus of analysts is that 3PAR would not be accretive to earnings for possibly years.

    With investors and traders looking for a reason to take advantage of HPQ's current low valuation, the news that 3PAR will go with DELL could be the beginning of the return of investors. 

    Disclosure: No positions
    Aug 26 8:57 AM | Link | Comment!
  • Stem Cell Stocks Hit by Negative Court Ruling--GERN and GENZ Best Positioned

    Right before the close today (August 23), a preliminary injunction was issued by a US District Court stopping the federal funding of human embryonic stem cell research

    Judge Royce Lamberth granted the injunction after finding that the lawsuit would likely succeed because the guidelines violated law banning the use of federal funds to destroy human embryos. A Reuters article said, "The unusual suit against the National Institutes of Health, backed by some Christian groups opposed to embryo research, argued that the NIH policy violates U.S. law and takes funds from researchers seeking to work with adult stem cells."The Federal Governmentt has the option to appeal the decision or try to rewrite the guidelines to comply with U.S. law.

    Any  selloff in the names that have an interest in stem cells
    could be an opportunity for those traders that have some risk tolerance. Companies like Geron (Nasdaq:GERN) and Genzyme (Nasdaq:GENZ) which are not associated as pure plays in the Stem Cell sector may offer a profitable trade or entry.


    Disclosure: No positions
    Aug 23 5:38 PM | Link | Comment!
Full index of posts »
Latest Followers


  • Digesting The GMO Food Controversy And What It Means For Your Investment Portfolio
    Jul 10, 2014
  • European markets cratered on Labor Day, setting the stage for a 250-300 point drop in the DOW when traders return on Tuesday.
    Sep 5, 2011
  • Competitive Technologies (CTTC, $1.75) for continued strength after chronic pain technology is highlighted on two TV morning shows tomorrow.
    Mar 14, 2011
More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.